Heritage Wealth Advisors Has $162,000 Holdings in Walgreens Boots Alliance Inc (WBA)

Heritage Wealth Advisors boosted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 225.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,562 shares of the pharmacy operator’s stock after purchasing an additional 1,775 shares during the period. Heritage Wealth Advisors’ holdings in Walgreens Boots Alliance were worth $162,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. CSat Investment Advisory L.P. increased its stake in shares of Walgreens Boots Alliance by 12.1% during the fourth quarter. CSat Investment Advisory L.P. now owns 1,920 shares of the pharmacy operator’s stock valued at $131,000 after buying an additional 208 shares during the period. Pathlight Investors LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $524,000. Roman Butler Fullerton & Co. boosted its position in shares of Walgreens Boots Alliance by 28.8% during the first quarter. Roman Butler Fullerton & Co. now owns 22,127 shares of the pharmacy operator’s stock valued at $1,400,000 after purchasing an additional 4,942 shares in the last quarter. James Investment Research Inc. bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $963,000. Finally, Tiemann Investment Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 2.7% during the fourth quarter. Tiemann Investment Advisors LLC now owns 22,190 shares of the pharmacy operator’s stock valued at $1,516,000 after purchasing an additional 586 shares in the last quarter. 64.77% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance stock opened at $52.50 on Friday. The firm has a market cap of $48.22 billion, a P/E ratio of 8.72, a PEG ratio of 1.07 and a beta of 0.77. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. Walgreens Boots Alliance Inc has a one year low of $51.79 and a one year high of $86.31.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 EPS for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). The firm had revenue of $34.53 billion for the quarter, compared to analysts’ expectations of $34.57 billion. Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.73 EPS. As a group, research analysts anticipate that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 3.35%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s payout ratio is 29.24%.

Several equities research analysts have commented on WBA shares. Citigroup dropped their target price on Walgreens Boots Alliance from $76.00 to $60.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. UBS Group initiated coverage on Walgreens Boots Alliance in a research note on Thursday, January 17th. They issued a “sell” rating and a $70.00 price target for the company. ValuEngine cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Friday, March 1st. Morgan Stanley decreased their price target on Walgreens Boots Alliance from $77.00 to $67.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 5th. Finally, Bank of America restated an “underperform” rating and issued a $62.00 price target (down previously from $69.00) on shares of Walgreens Boots Alliance in a research note on Friday, March 8th. Five investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $68.00.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the sale, the chief accounting officer now owns 435,811 shares in the company, valued at $23,119,773.55. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Ornella Barra purchased 18,000 shares of Walgreens Boots Alliance stock in a transaction on Wednesday, April 3rd. The stock was bought at an average price of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now owns 26,425 shares of the company’s stock, valued at $1,441,748. The disclosure for this purchase can be found here. Corporate insiders own 15.73% of the company’s stock.

WARNING: “Heritage Wealth Advisors Has $162,000 Holdings in Walgreens Boots Alliance Inc (WBA)” was published by Stock Observer and is owned by of Stock Observer. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://www.thestockobserver.com/2019/05/17/heritage-wealth-advisors-has-162000-holdings-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Do Tariffs Work?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.